TI SPEND Trademark

Trademark Overview

On Tuesday, March 1, 2016, a trademark application was filed for TI SPEND with the United States Patent and Trademark Office. The USPTO has given the TI SPEND trademark a serial number of 86924743. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, March 30, 2023. This trademark is owned by QPharma, Inc.. The TI SPEND trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Technology solution for life sciences companies, namely, providing temporary use of non-downloadable computer software for tracking, aggregating, and reporting transfers of value, namely, any monies or gifts rendered or paid to paid to healthcare professionals and hospitals from life sciences companies to covered recipients in compliance with transparency regulations including the federal Sunshine Act and applicable state-specific regulations
ti spend

General Information

Serial Number86924743
Word MarkTI SPEND
Filing DateTuesday, March 1, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, March 30, 2023
Registration Number5272097
Registration DateTuesday, August 22, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements

Disclaimer with Predetermined Text"SPEND"
Goods and ServicesTechnology solution for life sciences companies, namely, providing temporary use of non-downloadable computer software for tracking, aggregating, and reporting transfers of value, namely, any monies or gifts rendered or paid to paid to healthcare professionals and hospitals from life sciences companies to covered recipients in compliance with transparency regulations including the federal Sunshine Act and applicable state-specific regulations

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 15, 2016
Primary Code042
First Use Anywhere DateTuesday, March 1, 2016
First Use In Commerce DateTuesday, March 1, 2016

Trademark Owner History

Party NameQPharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameQPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameQPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960

Trademark Events

Event DateEvent Description
Thursday, March 30, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, March 30, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 30, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 19, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, August 22, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 22, 2017REGISTERED-PRINCIPAL REGISTER
Saturday, July 15, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, July 14, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, June 24, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, May 26, 2017USE AMENDMENT FILED
Friday, June 23, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 26, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, May 23, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 22, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 21, 2017DATA MODIFICATION COMPLETED
Tuesday, February 21, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, February 21, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 21, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, February 21, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 23, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 23, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 15, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 15, 2016NON-FINAL ACTION E-MAILED
Thursday, September 15, 2016NON-FINAL ACTION WRITTEN
Thursday, September 15, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 15, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 31, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 31, 2016NON-FINAL ACTION E-MAILED
Wednesday, August 31, 2016NON-FINAL ACTION WRITTEN
Wednesday, August 31, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 31, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 25, 2016ASSIGNED TO LIE
Wednesday, August 17, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 16, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 16, 2016NON-FINAL ACTION E-MAILED
Thursday, June 16, 2016NON-FINAL ACTION WRITTEN
Tuesday, June 14, 2016ASSIGNED TO EXAMINER
Friday, March 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

spend companies regulations sciences namely life paid covered recipients hospitals compliance